When Experience, Expertise and Connections Count

Led by one of the nation’s top health care leaders, Wexford Solutions will ensure you surpass your goals. Building on decades of experience and relationships with decision makers in Washington D.C. and health care executives nationwide, Wexford is your answer.

Access to Decision Makers

Long-time hospital industry CEO with close ties to senior leaders. Including Congress, Administration, hospital C-Suite and pharmacy executives.

Government Relations

Decades of experience with key policymakers. Unparalleled understanding of hospital and pharmaceutical policy. Ensure you are well-represented in Washington.


Gifted Writer/Speaker. Innovative thought leader. Strong relations with media to ensure your message is delivered.

Business Development

Build and strengthen your market power. Essential guidance and support from an experienced entrepreneur.



1 week ago
Definitely check out @340B_Report's #340B Industry Leader profile of @mcwallack, CEO of Rx|X, a great #340B consulting firm. @mcwallack has had a quite a history in #340B and has great hobbies outside of #340B! https://t.co/HNRIWQnjTH
1 week ago
Great to have @Apexus340B as a @340B_Report sponsor. Learn more about becoming a #340B ACE in this article. https://t.co/jzKiQFLOl0
1 week ago
It was a real pleasure talking to Ken Perez of @Omnicell about the key issues impacting #340B stakeholders during this challenging and exciting time. I think you will find our 15-20 minute discussion worth the listen. You can go directly to the podcast: https://t.co/iSYSDyXQT9 https://t.co/HLpcVbfxTY
Omnicell @Omnicell
The 340B Drug Pricing Program is a vital source of funding for patient care, but significant challenges are threatening the program and safety-net providers. Listen to our latest podcast as we sort through the legal, policy, and financial complexities.

https://t.co/mmJsIocyrP https://t.co/2HEFzJRWJ6

News & Articles

Time for Congress to Break the 340B Contract Pharmacy Logjam

As of publication time, eight pharmaceutical manufacturers either have stopped offering or placed significant restrictions on 340B discounts when a provider contracts with a retail or community … Read

Legislation that 340B Providers and the Drug Industry Can Both Embrace

Imagine if there was a way to resolve two of the most intractable challenges in the 340B program in one fell swoop: one that has a significant impact on the financial health of 340B providers, and … Read

More News & Commentary


The Hon. Henry Waxman

Fmr. Chairman, House Energy & Commerce Committee and House Oversight & Government Reform Committee

Ted has dedicated his career to tackling some of the most important and complex health care policy challenges facing the nation.  He is a leading voice and thinker on health care access issues and I appreciate his advice and counsel.  I have had the pleasure to work with him and consider him a good friend and colleague.

The Hon. Gil Gutknecht

Member of U.S. House of Representatives (1995-2007)

I really enjoy working with Ted. He has a unique ability to connect with people and is an excellent strategic thinker. He is a great communicator and a thoughtful writer. He also has very good relationships on both sides of the political aisle, which is very important in Washington.

Let us know how we can help